Matresa Limited

Based in the United Kingdom, Matresa Limited is a maternal health company that provides a preventative health platform for women navigating the transitions of pregnancy and early motherhood, emphasizing personalized guidance and support. Matresa Limited is focused on providing a preventative maternal health platform that supports women during their matrescence journey. The company was founded in the UK in 2025 by Mari-Carmen Sanchez-Morris (CEO as of 2026). In February 2026, Matresa raised GBP 315,000 in pre-seed funding led by SFC Capital.

This funding was aimed at expanding the platform's availability across the UK and enhancing access to pregnancy and postnatal care monitoring. Matresa offers a comprehensive preventative maternal health platform designed to support women through the matrescence journey, which encompasses the neurological, psychological, physical, and identity transitions from pregnancy through early motherhood. The core product includes personalized guidance and continuous support, allowing mothers to access the right care at the right time. This service addresses the hidden risks associated with pregnancy and postpartum periods, ensuring that mothers feel seen, heard, and supported beyond traditional healthcare appointments.

The platform caters to both individual mothers and organizations, including employers seeking to enhance maternal benefits for their employees. Matresa's solutions are primarily targeted at markets in North America and Europe, where demand for comprehensive maternal health support is growing. Matresa generates revenue through a subscription-based model targeting both individual users and corporate clients. Employers can partner with Matresa to offer maternal health benefits as part of their employee wellness programs, providing essential support during maternity transitions.

The pricing structure accommodates both B2B transactions and direct-to-consumer subscriptions. By facilitating ongoing support and personalized insights, Matresa strengthens the connection between mothers and their healthcare providers, which helps improve maternal outcomes and workforce engagement. The company's flagship service ensures that users receive timely assistance and guidance tailored to their unique experiences during pregnancy and postpartum. In February 2026, Matresa Limited raised GBP 315,000 in pre-seed funding led by SFC Capital, which will be used to expand its platform's availability across the UK and support broader access to pregnancy and postnatal care monitoring.

The company is also planning to explore additional markets and regions to enhance their service reach.